Articlenpj drug discovery2026
Vector venom: venomics of Aedes albopictus reveals a large enzyme repertoire and novel cecropins with activity against E. coli.
Article in npj drug discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Mosquitoes are vectors of deadly diseases and pose a global health threat. Particularly, the Asian tiger mosquito Aedes albopictus can transmit several pathogens, and is expanding into temperate regions. During blood feeding, mosquitoes inject chemically complex saliva, here referred to as venom, which modulates hemostasis, inflammation, immune response and pathogen transmission. In-depth knowledge of mosquito venom is crucial for understanding disease biology and enabling biodiscovery. We present a venomics study of Ae. albopictus and identify 119 distinct proteins validated by mass spectrometry and transcriptomics. The venom is rich in enzymes (e.g., hydrolases and Apyrases) and non-enzymatic components (e.g., odorant binding proteins and protease inhibitors). Additionally, we identified six novel cecropin family antimicrobial peptides. Structural analyses indicate an amphipathic N-terminus, hinge region, and hydrophobic C-terminus consistent with type II channel formation. Functional assays revealed that these cecropins exert potent effects on E. coli while leaving mammalian epithelial cells and erythrocytes unaffected. Overall, our study reveals that mosquito venom is a source of diverse biomacromolecules, deepening our understanding of its physiology, vector biology, and biochemical ecology. This opens paths for new mosquito-control strategies and drug discovery.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.